πŸ‡ΊπŸ‡Έ FDA
Patent

US 9163068

Influenza virus recombinant proteins

granted A61KA61K2039/55566A61K2039/575

Quick answer

US patent 9163068 (Influenza virus recombinant proteins) held by The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer
Grant date
Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/55566, A61K2039/575, A61K39/00, A61K39/12